CHU Grenoble Alpes, with Nantes, Rennes and Toulouse
LADY-PD — the menstrual cycle and Parkinson's symptoms in women in France
A France Parkinson-funded study across four French expert centres, led from Grenoble, in which pre-menopausal women with Parkinson's attend two clinic visits six months apart and track symptoms and medication across the menstrual cycle in a French version of the My Moves Matter app.

Why this research matters
The women's research with University College Cork relied on women tracking themselves at home. LADY-PD takes the same question, how the menstrual cycle relates to Parkinson's symptoms, into French expert centres, with neurologists following the women who take part. France Parkinson, which funds the study, notes that many younger women report their symptoms worsening in the week before their period and that treatments are sometimes less effective at that time, and that these differences need to be understood so that care can be adapted to hormonal fluctuations.
Design
A prospective observational study for pre-menopausal women with Parkinson's. Participants attend two visits, six months apart, at one of four expert centres: CHU Grenoble Alpes, CHU de Nantes, CHU de Rennes or CHU de Toulouse. Each visit includes questionnaires and clinical assessments designed to understand how the menstrual cycle affects symptoms; the study examines hormonal, clinical, biological and social aspects together. Between visits, women track their symptoms and medication across their cycle in LADY-PD, the French-language version of the My Moves Matter app. The study is coordinated from Grenoble by Professor Elena Moro.
Who can take part
As published by France Parkinson: women aged 18 to 56, diagnosed with Parkinson's for at least two years, not yet menopausal, on stable Parkinson's medication, and living in one of the participating regions (Auvergne-Rhône-Alpes, Bourgogne-Franche-Comté, Bretagne, Centre-Val de Loire, Normandie, Nouvelle-Aquitaine, Occitanie, PACA, Pays de la Loire). Women interested in taking part speak to their neurologist, who checks eligibility and arranges contact with a centre; the information document is read and discussed before any decision, and participation can be stopped at any time.
Status
Recruiting. France Parkinson is actively inviting eligible women to take part through the four centres. Participant numbers have not been published by the study team. No results are available yet.
What this study can show
LADY-PD can describe how symptoms vary across the menstrual cycle under clinical follow-up and how tracked data relates to clinical assessment. It is not a treatment trial, and no claims about treatment effects are made here.
The app used in this study
Participants tracked in the My Moves Matter App, our established mobile app for everyday tracking (the French-language LADY-PD version). It is a separate product from My Moves Matter Connect, the platform's newer connected tracking experience. About the app and how to get it.
Facts on this page last reviewed 2026-10-24.
